Thy Michael, Tanaka Sébastien, Tran-Dinh Alexy, Ribeiro Lara, Lortat-Jacob Brice, Donadio Julia, Zappella Nathalie, Ben-Rehouma Mouna, Tashk Parvine, Snauwaert Aurelie, Atchade Enora, Grall Nathalie, Montravers Philippe
Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Anesthesiology and Critical Care Medicine, Bichat-Claude Bernard Hospital, Paris, France.
EA 7323 - Pharmacology and Therapeutic Evaluation in Children and Pregnant Women, Paris Descartes University, Sorbonne Paris Cité University, Paris, France.
Front Med (Lausanne). 2021 Mar 4;7:609497. doi: 10.3389/fmed.2020.609497. eCollection 2020.
Recent studies described the threat of emerging multidrug-resistant (MDR) bacteria in intensive care unit (ICU) patients, but few data are available for necrotizing skin and soft tissue infections (NSTI). In a cohort of ICU patients admitted for NSTI, we describe the dynamic changes of microbial population during repeated surgeries. This retrospective study compiled consecutive cases admitted for the management of severe NSTI. Clinical characteristics, NSTI features, morbidity and mortality data were collected. The microbiological characteristics of surgical samples obtained during initial surgery were compared with those obtained during the first reoperation, including persistence of initial pathogens and/or emergence of microorganisms. Risk factors for emergence of microorganisms and MDR bacteria were assessed by univariable and multivariable analyses. Among 100 patients {63% male, 58 years old [interquartile ratio (IQR) 50-68]} admitted for NSTI, 54 underwent reoperation with a median [IQR] delay of 3 (1-7) days. Decreased proportions of susceptible strains and emergence of Gram-negative bacteria, including , staphylococci and enterococci strains, were reported based on the cultures of surgical specimen collected on reoperation. On reoperation, 22 (27%) of the isolated strains were MDR ( < 0.0001 vs. MDR bacteria cultured from the first samples). Broad-spectrum antibiotic therapy as first-line therapy was significantly associated with a decreased emergence of microorganisms. Adequate antibiotic therapy from the initial surgery did not modify the frequency of emergence of microorganisms ( = 0.79) and MDR bacteria ( = 1.0) or the 1-year survival rate. The emergence of microorganisms, including MDR bacteria, is frequently noted in NSTI without affecting mortality.
近期研究描述了重症监护病房(ICU)患者中出现的多重耐药(MDR)细菌的威胁,但关于坏死性皮肤和软组织感染(NSTI)的数据却很少。在一组因NSTI入院的ICU患者中,我们描述了重复手术期间微生物群落的动态变化。这项回顾性研究收集了因严重NSTI接受治疗的连续病例。收集了临床特征、NSTI特征、发病率和死亡率数据。将初次手术时获得的手术样本的微生物学特征与首次再次手术时获得的样本进行比较,包括初始病原体的持续存在和/或微生物的出现。通过单变量和多变量分析评估微生物和MDR细菌出现的危险因素。在100例因NSTI入院的患者中(63%为男性,58岁[四分位间距(IQR)50 - 68]),54例接受了再次手术,中位[IQR]延迟时间为3(1 - 7)天。根据再次手术时收集的手术标本培养结果,报告了敏感菌株比例下降以及革兰氏阴性菌的出现,包括葡萄球菌和肠球菌菌株。再次手术时,分离出的菌株中有22株(27%)为MDR(与首次样本培养出的MDR细菌相比,<0.0001)。作为一线治疗的广谱抗生素治疗与微生物出现减少显著相关。初次手术时的充分抗生素治疗并未改变微生物(=0.79)和MDR细菌(=1.0)的出现频率或1年生存率。在NSTI中经常会出现包括MDR细菌在内的微生物,但不影响死亡率。